Newsroom

PARIS--(BUSINESS WIRE)--Egle Therapeutics, a clinical-stage biotechnology company developing therapies targeting regulatory T cells (Tregs) for immuno-oncology and autoimmune diseases, will present two posters at the American Association for Cancer Research Annual Meeting (AACR) 2025 being held in Chicago April 25-30, 2025. In the poster, entitled “Preferential tumor uptake and retention of EGL-001, an anti-CTLA4-IL2 mutein fusion antibody achieving selective tumor Treg depletion”. Egle Therape...

NEW YORK & MUNICH--(BUSINESS WIRE)--Celonis today announced that it has been named a Leader in the Gartner Magic Quadrant for Process Mining Platforms for the third time....

LONDON--(BUSINESS WIRE)--FICO (NYSE: FICO): Highlights: More than £7B in annual lending at Lloyds Banking Group is powered by FICO® Platform Data ingestion of real-time bureau data drove a 2.5% credit card approval uplift and doubled new-to-bank consumer loan approvals 50+ system limitations and pain points resolved, with more to follow LBG wins 2025 FICO® Decision Award for Cloud Deployment As part of an ambitious programme to move its lending infrastructure to the cloud, Lloyds Banking Group...

LAUSANNE, Switzerland & SAN JOSE, Calif.--(BUSINESS WIRE)--Calling all sharpshooters, trackers, and gamers hungry for a challenge! Logitech G, a brand of Logitech (SIX: LOGN) (NASDAQ: LOGI) and leader in gaming technologies and gear, has teamed up with Aimlabs, the #1 aim trainer trusted by over 40 million players, for the second consecutive year. This year’s Logitech G PLAYDAYS x Aimlabs event is bigger, bolder, and stacked with can’t-miss action, including over $100K worth of Logitech G prize...

GALWAY, Ireland--(BUSINESS WIRE)--Perfuze, a leader in next-generation catheter-based technology for the treatment of acute ischemic stroke, today announced two significant milestones in its mission to improve stroke care: 1) the completion of patient enrollment in its U.S. pivotal IDE clinical trial, MARRS (Millipede Aspiration for Revascularization in Stroke Study), and 2) the appointment of seasoned medtech executive Joe Rotger as Executive Vice President of Sales. The MARRS pivotal study, c...

MUNICH & PFORZHEIM, Germany--(BUSINESS WIRE)--Electricity from renewable sources has become the new normal – in Germany alone, around 60 percent of net electricity generation came from renewables in 2024. But the growing volume of green power is posing new challenges for energy supply: The integration into the existing system urgently requires more flexibility. A Euroelectric/EY study forecasts a doubling of daily European flexibility demand by 2030 compared to 2021, potentially reaching 1.8 TW...

MÜNCHEN & PFORZHEIM, Deutschland--(BUSINESS WIRE)--Die wachsende Menge an grünem Strom stellt die Energieversorgung vor neue Herausforderungen: Die Integration in das bestehende System erfordert dringend mehr Flexibilität. Eine aktuelle Studie des europäischen Branchenverbands Eurelectric in Zusammenarbeit mit EY zeigt, dass der Flexibilitätsbedarf in Europa bis 2030 voraussichtlich doppelt so hoch sein wird. Im Vergleich zu 2021 wird ein Anstieg um das 2,4-Fache auf Tagesbasis – von vormals 15...

LONDON--(BUSINESS WIRE)--10x Banking unveils new AI capabilities for its cloud-native core banking platform to accelerate banking & financial services transformation....

BASEL, Switzerland--(BUSINESS WIRE)--Malaria gehört zu den tödlichsten Krankheiten der Welt und breitet sich trotz jahrzehntelanger Bemühungen und einiger Erfolge auf dem Weg zur Ausrottung weiter aus. Nach Angaben der Weltgesundheitsorganisation (WHO) infizierten sich weltweit 263 Millionen Menschen mit Malaria, und allein im Jahr 2023 starben beinahe 600 000 Menschen an der Krankheit – 75 % davon Kinder unter fünf Jahren. 94% der Erkrankten leben in Afrika, wo Malaria ganze Gemeinden zerstöre...

巴塞尔--(BUSINESS WIRE)--(美国商业资讯)-- 疟疾是全球致命性最强的疾病之一。尽管人类数十年的防控努力取得了阶段性成果，其威胁却仍在加剧。世界卫生组织（WHO）数据显示，2023年全球疟疾感染人数达2.63亿，导致近60万人死亡，其中75%为5岁以下儿童。94%的感染病例集中在非洲——在当地，疟疾不仅破坏社区发展，更重创经济。 疟疾通过携带疟原虫的蚊虫传播，而这类蚊虫具有极强的进化适应能力，其蔓延态势不仅反映出杀虫剂抗性广泛存在的现实情况，也凸显了新防控方案研发所面临的严峻挑战。在此背景下，蚊虫的有效防控仍是阻断疾病传播的核心策略。 全球农业创新领军企业先正达今日宣布，新一代杀虫剂Sovrenta®正式获得世界卫生组织预认证，为其在疟疾肆虐国家的落地应用铺平道路。数十年来，先正达一直站在抗击疟疾的前线，通过自主研发，并与撒哈拉以南非洲地区核心伙伴深度合作，积极探索创新解决方案。旗下Actellic®等产品已帮助30余个国家成功预防超1亿疟疾病例。 Sovrenta®通过靶向蚊虫神经系统，阻断其肌肉放松信号传导，从而使其麻痹并最终死亡。长效防控，单季单次施药即可见效，...